Table 1.

Summary of patients data.

Pa- tient no.	Age	Sex	Indication	Location	Stent diameter and length	Morphology	Immediate aneurysms obliteration	Complications	Pharmacolo- gical treatment
1	54	F	SAH	ICA	3.5 x 12	BN	CO		ASA
2	28	M	SAH	PICA	2.5 x 12	BN	CO		ASA
3	53	F	SAH	ICA	3.5 x 18	BN	CO		ASA
4	56	M	SAH	BA	2.5 x 18	BN	CO		ASA
5	43	F	SAH	BA tip	2.5 x 18	BN	CO	TB	ASA
6	62	F	SAH	ICA	3.5 x 18	BN	CO		ASA
7	18	F	SAH/coils protrusion	A2	2.5 x 18	BN	CO	TB	-
8	53	F	SAH	BA	2.5 x 12	BN	CO		ASA
9	54	F	SAH	ICA	4.5 x 25	BN	INC		ASA
10	50	M	SAH	M1/M2	2.5 x 12	BN	CO		ASA
11	44	M	SAH	BA tip	2.5 x 12	BN		TB/ death	ASA
12	25	F	SAH	ICA	3.5 x 25	BN	INC		ASA
13	47	M	SAH	BA tip	2.5 x 18	BN	CO		ASA
14	55	F	SAH	ICA	3.5 x 18	BN	CO	death	ASA
15	54	F	SAH	ICA	4.5 x 25	BN	CO		ASA
16	54	M	SAH	PICA	2.5 x 12	BN	CO		ASA
17	51	M	SAH	VA	3.5 x 18	F	NO		ASA
18	45	M	SAH	BA	2.5 x 12	BN	NO		-
19	61	F	pSAH	ICA	4.5 x 20	BN	CO		ASA, ticlo
20	49	F	pSAH	ICA	3.5 x 25	BN	CO		ASA, ticlo
21	44	M	Inc	BA	4.5 x 50	F	NO		ASA, ticlo
22	47	M	Headache	BA	4.5 x 50	F	NO		ASA, ticlo
23	43	M	Inc	ICA	4.5 x 20	BN	CO		ASA, ticlo
24	44	F	Inc	ICA	3.5 x 18	BN	CO		ASA, ticlo
25	54	F	CNP	ICA	4.5 x 20	BN	x		ASA, ticlo
26	57	F	Inc	ICA	3.5 x 18	BN	x		ASA, ticlo
27	47	F	Inc	ICA	4.5 x 40	BN	x		ASA, ticlo
28	49	F	Headache	ICA	3.5 x 25	BN	x		ASA, ticlo
SAH, Subarachnoid haemorrhage; ICA, internal carotid artery; BN, broad-necked; BA tip, tip of basilar artery; TB, thrombosis ASA, acetylsalicylic acid; PICA, posterior inferior cerebellar artery; BA, basilar artery; INC, incomplete; M1/M2, M1/M2 segment of middle cerebral artery; A2, A2 segment of anterior cerebral artery; VA, vertebral artery; F, fusiform; pSAH, pimary SAH, at least 12 month ago, Inc, incidental; CNP cranial nerve palsy; ticlo, ticlopidine; CNP, cranial nerves palsy; x - coils embolization planned in the future.